drugset / Trial / NCT00458107

Study Evaluating the Safety and Tolerability of SCA-136 in Healthy Japanese and Non-Japanese Female Subjects

NCT00458107

Phase 1 Completed 64 enrolled Wyeth is now a wholly owned subsidiary of Pfizer
RandomizedSingle-groupDouble-blindTreatment

Summary

This study is being conducted to evaluate the safety and tolerability of ascending multiple oral doses of SCA-136 adminstered to healthy Japanese and non-Japanese female subjects.

Timeline

Start
2007-04
Primary completion
Completion
2007-09

Drugs

EvaluationDrugModalityDoseRoute
Subject vabicaserin Small molecule Oral

Indications